In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic.

Recent immunocytochemical and morphometric studies in amyotrophic lateral sclerosis, Alzheimer's disease (AD), and aging indicate that the neuronal Golgi apparatus is a reliable index of activity or degeneration. To further evaluate a possible role of the Golgi apparatus in the pathogenesis of AD, we examined by double labeling the neuronal Golgi apparatus, neurofibrillary tangles (NFTs), and senile plaques (SPs) in the hippocampus of six cases of AD, and in 13 controls including three cases of a rare form of dementia lacking distinctive histopathological features. The Golgi apparatus was visualized with a polyclonal antiserum against MG-160, a membrane sialoglycoprotein of the organelle, and NFTs and SPs were visualized with biotinylated basic fibroblast growth factor (bFGF). Only a rare SP contained a few small immunostained elements of the Golgi apparatus. Neurons with intracellular NFTs, labeled with biotinylated bFGF, contained intensely labeled but deformed Golgi apparatus, which was displaced by the NFTs and coalesced into larger irregular granules. In contrast, a population of neurons without NFTs displayed fragmentation of the Golgi apparatus, ie, the organelle appeared in the form of small round, disconnected, and dispersed elements instead of the normal perinuclear network of irregular or linear profiles which often extended into the proximal segments of dendrites. In addition, the fragmented neuronal Golgi apparatus was atrophic as the percentage of the cell surface area occupied by the organelle was 4.4 +/- 0.6% SD, whereas in neurons with a normal Golgi apparatus the percentage of the cell surface area occupied by the organelle was 10.3 +/- 0.3% SD. The results of this study suggest that in AD the Golgi apparatus of a population of neurons without NFTs is involved in the pathogenesis of the disease. Considering the role of the Golgi apparatus in the processing of polypeptides destined for fast axoplasmic transports, the fragmentation of the organelle may be associated with functional and structural impairments of axons and presynaptic terminals.

[1]  J. Morris,et al.  Mesolimbocortical dementia. A clinicopathologic case study of a putative disorder. , 1986, Archives of neurology.

[2]  Z. Mourelatos,et al.  Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in beta,beta'-iminodipropionitrile axonopathy. , 1994, The American journal of pathology.

[3]  R. Terry,et al.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.

[4]  M. Jaye,et al.  Adult Brain but Not Kidney, Liver, Lung, Intestine, and Stomach Membrane Preparations Contain Detectable Amounts of High‐Affinity Receptors to Acidic and Basic Growth Factors a , 1991, Annals of the New York Academy of Sciences.

[5]  Brian J Cummings,et al.  Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.

[6]  P. Johnston,et al.  A hypothesis on the traffic of MG160, a medial Golgi sialoglycoprotein, from the trans-Golgi network to the Golgi cisternae. , 1994, Journal of cell science.

[7]  R. Kalaria,et al.  Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. , 1994, American Journal of Pathology.

[8]  Basic Fibroblast Growth Factor Prevents Retrograde Degeneration of the Thalamic Neurons After Ablation of the Somatosensory Cortex , 1993 .

[9]  A. Tartakoff,et al.  The response of the Golgi complex to microtubule alterations: the roles of metabolic energy and membrane traffic in Golgi complex organization , 1989, The Journal of cell biology.

[10]  E. Stopa,et al.  Basic fibroblast growth factor in Alzheimer's disease. , 1990, Biochemical and biophysical research communications.

[11]  Seng H. Cheng,et al.  Intracellular protein trafficking defects in human disease. , 1992, Trends in cell biology.

[12]  P. Cras,et al.  Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  G. Palade,et al.  The Golgi apparatus (complex)-(1954-1981)-from artifact to center stage , 1981, The Journal of cell biology.

[14]  M. Farquhar.  Progress in unraveling pathways of Golgi traffic. , 1985, Annual review of cell biology.

[15]  M. Lenter,et al.  The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor , 1995, Nature.

[16]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[17]  G. Peters,et al.  Retention of fibroblast growth factor 3 in the Golgi complex may regulate its export from cells , 1993, Molecular and cellular biology.

[18]  J. Wegiel,et al.  COMPUTER-ASSISTED 3D-RECONSTRUCTION OF THE HIPPOCAMPAL FORMATION IN AD , 1993 .

[19]  J. Brosius,et al.  MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast growth factor receptor. , 1995, Journal of cell science.

[20]  R. Ravid,et al.  Decreased Activity of Hippocampal Neurons in Alzheimer's Disease Is Not Related to the Presence of Neurofibrillary Tangles , 1995, Journal of neuropathology and experimental neurology.

[21]  S. Young,et al.  Neuronal Fibrillar Cytoskeleton and Endomembrane System Organization in Alzheimer’s Disease , 1987 .

[22]  T. Yamashita,et al.  Messenger RNA and protein expression of basic fibroblast growth factor receptor after cortical ablation. , 1994, Brain research. Molecular brain research.

[23]  D. Swaab,et al.  Activation of Vasopressin Neurons in Aging and Alzheimer's Disease , 1994, Journal of neuroendocrinology.

[24]  K. Kosik,et al.  The Alzheimer's disease sphinx: a riddle with plaques and tangles , 1994, The Journal of cell biology.

[25]  D. Knopman,et al.  Dementia lacking distinctive histologie features , 1990, Neurology.

[26]  F. Gage,et al.  Spinal cord neuroblasts proliferate in response to basic fibroblast growth factor , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[28]  M. Roth,et al.  Absence of Abnormal Hyperphosphorylation of Tau in Intracellular Tangles in Alzheimer's Disease , 1995, Journal of neuropathology and experimental neurology.

[29]  Kazunori Koiwai,et al.  The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques , 1991, Neuroscience Letters.

[30]  P. Cras,et al.  Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  J. Hauw,et al.  Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. , 1992, The American journal of pathology.

[32]  R. Morrison.  Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. , 1991, The Journal of biological chemistry.

[33]  Brian J Cummings,et al.  Neuritic Involvement within bFGf Immunopositive Plaques of Alzheimer's Disease , 1993, Experimental Neurology.

[34]  R. Ravid,et al.  Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus , 1994, Neuroscience.

[35]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[36]  S. Croul,et al.  Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  J. Changeux,et al.  Nerve‐Dependent Plasticity of the Golgi Complex in Skeletal Muscle Fibres: Compartmentalization Within the Subneural Sarcoplasm , 1995, The European journal of neuroscience.

[38]  L. Rorke,et al.  The Golgi apparatus of moptor neurons in amyotrophic lateral sclerosis , 1993, Annals of neurology.

[39]  R Guillemin,et al.  Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Perry,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[42]  M. Sensenbrenner.  The neurotrophic activity of fibroblast growth factors , 1993, Progress in Neurobiology.

[43]  N. Gonatas.  Rous-Whipple Award Lecture. Contributions to the physiology and pathology of the Golgi apparatus. , 1994, The American journal of pathology.

[44]  N. Gonatas,et al.  MG-160. A novel sialoglycoprotein of the medial cisternae of the Golgi apparatus [published eeratum appears in J Biol Chem 1989 Mar 5;264(7):4264]. , 1989, The Journal of biological chemistry.

[45]  D. Swaab,et al.  Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus , 1995, Neuroscience Letters.

[46]  C. Cotman,et al.  Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo , 1988, Nature.

[47]  P. Fraser,et al.  An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.

[48]  S. Avrameas,et al.  In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells. , 1980, Journal of immunology.

[49]  Douglas C. Miller,et al.  Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. , 1990, Cancer research.

[50]  H. Uylings,et al.  Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease , 1994, Neurobiology of Aging.

[51]  M. Gurney,et al.  Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS) , 1995, Brain Research.

[52]  R. Ravid,et al.  Activation of the human supraptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus , 1993, Brain Research.

[53]  C. Cotman,et al.  Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  D. Swaab,et al.  Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity , 1995, Brain Research.

[55]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[56]  Z. Mourelatos,et al.  Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  B. Pakkenberg,et al.  No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type , 1994, Neurobiology of Aging.

[58]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[59]  F. Eckenstein,et al.  Differential Localization and Possible Functions of aFGF and bFGF in the Central and Peripheral Nervous Systems a , 1991, Annals of the New York Academy of Sciences.

[60]  M. Kidd.  Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.

[61]  P. Lacy,et al.  New Hypothesis of Insulin Secretion , 1968, Nature.

[62]  E. Masliah,et al.  The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System , 1993, Brain pathology.

[63]  I. Rainero,et al.  Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder , 1990, Nature.

[64]  Z. Mourelatos,et al.  MG160, a membrane protein of the Golgi apparatus which is homologous to a fibroblast growth factor receptor and to a ligand for E-selectin, is found only in the Golgi apparatus and appears early in chicken embryo development. , 1995, Experimental cell research.